Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Half Of Breakthrough Designations Have Resulted In Approval

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Apr 27, 2022 6:43pm

191 Views

Post# 34637216

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Half Of Breakthrough Designations Have Resulted In Approval

Clear data is when your data is statistically superior to all other competitors and that it cannot regress below theirs, no matter how many patients you add.

FDA approval is the end of the process, that includes data and any other considerations.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland